Home Tags EGFR Amplified Recurrent Glioblastoma

Tag: EGFR Amplified Recurrent Glioblastoma

Rare Pediatric Disease Designation for ABT-414 for the Treatment of a...

The U.S. Food and Drug Administration (FDA) has a granted Rare Pediatric Disease Designation for AbbVie's ABT-414, an investigational antibody-drug conjugate (ADC) targeting the...

ABT-414 Shows Encouraging Phase I Results in Monotherapy in Patients with...

Safety and preliminary efficacy data from a phase I study of ABT-414 (AbbVie) – an investigational antibody drug conjugate or ADC for the treatment of...

X